ORIGINAL RESEARCH article
Front. Med.
Sec. Obstetrics and Gynecology
This article is part of the Research TopicAdvances in New Biomarkers for the Diagnosis and Therapy of Gynaecological TumoursView all 13 articles
Risk factors of histologic upgrade between colposcopy-directed biopsy and loop electrosurgical excision procedure in cervical squamous intraepithelial lesions: A retrospective study
Provisionally accepted- 1Department of Gynecology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
- 2Department of Gynecology, Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China
- 3Department of Traditional Chinese Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
- 4Department of Gynecology, Shanghai Pudong New Area People's Hospital, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The aim of this study is to compare the pathological outcomes between colposcopy-directed biopsy (CDB) and loop electrosurgical excision procedure (LEEP) in patients diagnosed with cervical squamous intraepithelial lesions (SIL), and to evaluate the risk factors correlated with histologic upgrade from CDB to subsequent LEEP conization. Methods: This retrospective study included a total of 1496 patients who underwent LEEP after receiving pathological confirmation of cervical SIL through CDB. Statistical analysis was employed to assess the risk factors associated with the histologic upgrade of biopsy. Results: The study cohort was composed of 410 patients initially categorized with LSIL and 1086 identified with HSIL, who subsequently underwent LEEP surgery. Among the LSIL-patients diagnosed via CDB, 79 showed instances of biopsy histologic upgrade. The analysis revealed that HPV16 (P<0.001, OR 95% CI [1.58,5.02]), HPV18 (P<0.001, OR 95%CI [2.11,9.29]), and type of cervical transformation zone (P<0.001) were substantial risk factors leading to histologic upgrade in patients identified with LSIL by CDB. Out of the 1086 patients who received pathological confirmation of HSIL through CDB, 19 were additionally diagnosed with cervical cancer. Among the upgraded patients, none represented type 1 cervical transformation zone. Furthermore, type 3 transformation zone was notably more susceptible to histologic upgrade compared to type 2 transformation zone (χ2 =8.83, P=0.003). Univariate analysis revealed HPV16 (P=0.049, OR 95%CI [1.00,6.58]) and HPV18 infection (P<0.001, OR 95% CI [2.50,18.40]) were significant contributors to the histologic upgrade of HSIL. Conclusions: Our study identified that HPV16/18 infection and a non-fully visible cervical transformation zone are significant risk factors associated with histologic upgrade between CDB and subsequent LEEP conization.
Keywords: Cervical squamous intraepithelial lesions, Colposcopy-directed biopsy, histolofic upgrade, HPV16/18 infection, Loop electrosurgical excision procedure
Received: 05 Dec 2025; Accepted: 13 Feb 2026.
Copyright: © 2026 Ma, Xu, Zhang, Zhi, Ma, Ling, Xu, Sun and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liyan Sun
Fang Li
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
